Sign Out
Prostate cancer: ZOLADEX/ZOLADEX LA is indicated in the management of prostate cancer suitable for hormonal manipulation.
Zoladex: Advanced breast cancer in pre- and peri-menopausal women suitable for hormonal manipulation.
Zoladex 3.6mg is indicated as an alternative to chemotherapy in the standard care for pre/peri-menopausal women with oestrogen receptor (ER) positive early breast cancer.
Endometriosis: In the management of endometriosis, ZOLADEX 3.6 mg alleviates symptoms, including pain, and reduces the size and number of endometrial lesions.
Endometrial thinning: ZOLADEX 3.6 mg is indicated for the prethinning of the uterine endometrium prior to endometrial ablation or resection.
Uterine fibroids: In conjunction with iron therapy in the haematological improvement of anaemic patients with fibroids, prior to surgery.
Assisted reproduction: Pituitary downregulation in preparation for superovulation.
Continue with Google